Carolina Specialty Care PA Addiction Medicine Services

Carolina Specialty Care PA Addiction Medicine Services

Services:
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient
• Regular outpatient treatment

Facility Smoking Policy

• Smoking not permitted

Gender Accepted

• Male
• Female

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Education and Counseling Services

• Health education services other than HIV/AIDS or hepatitis
• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support

Language Services

• Sign language services for the deaf and hard of hearing

Testing

• TB screening
• Testing for Hepatitis B (HBV)
• STD testing
• Testing for Hepatitis C (HCV)
• HIV testing
• Drug or alcohol urine screening
• Metabolic syndrome monitoring

External Opioid Medications Source

• In-network prescribing entity
• No formal relationship with prescribing entity

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Medical Services

• Hepatitis B (HBV) vaccination

Assessment/Pre-treatment

• Screening for substance use
• Screening for tobacco use
• Screening for mental disorders
• Professional interventionist/educational consultant
• Comprehensive substance use assessment
• Complete medical history/physical exam

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• No formal relationship with prescribing entity
• Other contracted prescribing entity

Type of Care

• Substance use treatment

Facility Vaping Policy

• Vaping not permitted

License/Certification/Accreditation

• SAMHSA certification for opioid treatment program (OTP)
• Drug Enforcement Agency (DEA)

Type of Opioid Treatment

• Prescribes naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Buprenorphine maintenance
• Prescribes buprenorphine

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care
• Naloxone and overdose education

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Naltrexone (oral)
• Acamprosate (Campral®)
• Medications for Hepatitis C treatment
• Buprenorphine without naloxone
• Clonidine
• Nicotine replacement
• Buprenorphine with naloxone
• Buprenorphine (extended-release, injectable)
• Medication for mental disorders
• Naltrexone (extended-release, injectable)
• Disulfiram

Payment/Insurance/Funding Accepted

• Private health insurance
• Medicare
• State-financed health insurance plan other than Medicaid
• Federal military insurance (e.g., TRICARE)
• Cash or self-payment
• Medicaid
• SAMHSA funding/block grants